CA Patent

CA2822698A1 — Her2 binding peptides labelled with a 18f - containing organosilicon compound

Assigned to GE Healthcare Ltd · Expires 2012-06-28 · 14y expired

What this patent protects

Imaging agents comprising an isolated polypeptide conjugated with a radionucleide and a chelator; wherein the isolated polypeptide binds specifically to HER2, or a variant thereof; and methods for preparing and using these imaging agents.

USPTO Abstract

Imaging agents comprising an isolated polypeptide conjugated with a radionucleide and a chelator; wherein the isolated polypeptide binds specifically to HER2, or a variant thereof; and methods for preparing and using these imaging agents.

Drugs covered by this patent

Patent Metadata

Patent number
CA2822698A1
Jurisdiction
CA
Classification
—
Expires
2012-06-28
Drug substance claim
No
Drug product claim
No
Assignee
GE Healthcare Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.